Junevity is a biotechnology company resetting gene networks with siRNA for age-related diseases. The Junevity RESET platform is the first to use human disease data, ML/AI and siRNA to identify and drug novel transcription factor targets. Initial programs are in cardiometabolism and neurodegeneration. Based in San Francisco and founded out of UCSF in 2023, Junevity’s mission is to increase lifespan and healthspan.
| Website | http://junevity.com |
| Employees | 13 (7 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Rna Interference, Sirna Therapeutics, Age Related Diseases, Therapeutic Platform, Drug Discovery, Biotechnology, Gene Therapy, Molecular Medicine, Regenerative Medicine, Aging Research, Disease Treatment, Pharmaceutical Research, Clinical Trials, Life Extension, Healthspan, Longevity, Anti-Aging |
| Competitors | WeightWatchers, Nutrisystem, Inc., MyFitnessPal, Slimfast, Noom, Jenny Craig, Fitbit (now part of Google), HealthifyMe, Lose It!, Yummly +40 more (view full list) |
Looking for a particular Junevity employee's phone or email?
Rob Cahill is the Co-founder, Chief Operating and Business Officer of Junevity.
7 people are employed at Junevity.
Junevity is based in San Francisco, California.